Last reviewed · How we verify
Pfizer Viagra
At a glance
| Generic name | Pfizer Viagra |
|---|---|
| Also known as | Sildenafil citrate |
| Sponsor | Aspargo Labs, Inc |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Sildenafil Plus Hypothermia to Treat Neonatal Encephalopathy (PHASE2)
- Phase 2 Efficacy Study of Sildenafil Products in Adult Men With Erectile Dysfunction (PHASE2)
- Cerebrovascular Reactivity Assessed With fNIRS as a Biomarker of TCVI After Acute Traumatic Brain Injury in Military (PHASE2)
- Evaluation of Metabolic Markers for the Prediction of DDI of Various CYP3A Substrates and Inhibitors (PHASE1)
- Intrapartum Sildenafil Citrate to Prevent Non Reassuring Foetal Status Among Parturients Delivering at Term (PHASE4)
- A Relative Bioavailability Study Between Two Formulations Of Sildenafil Citrate (PHASE1)
- A Study to Determine the Pharmacokinetic Profile, Safety and Tolerability of Sildenafil (REVATIO®) in Cardiac Surgery (PHASE1)
- Endurance Performance at Altitude (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Pfizer Viagra CI brief — competitive landscape report
- Pfizer Viagra updates RSS · CI watch RSS
- Aspargo Labs, Inc portfolio CI